Endocardial radiofrequency ablation of septal hypertrophy: A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy

Zeitschrift fur Kardiologie

Volumn 93, Issue 6, 2004, Pages 493-499

  Lawrenz, T ^a   Kuhn, H ^a  

^a OWL University   (Germany)

Author keywords

Alcohol septal ablation; Cooled radiofrequency ablation; Hypertrophic cardiomyopathy; Irrigated tip catheter; TASH

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CATHETER ABLATION; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TEST; HEART ARRHYTHMIA; HEART CATHETERIZATION; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE SEPTUM HYPERTROPHY; HUMAN; PRESSURE GRADIENT; RADIOFREQUENCY;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ENDOCARDIUM; ETHANOL; HEART SEPTUM; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 3042802513     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Breithardt OA, Stolle B, Franke A, Janssens U, Hanrath P, Kuhn H (2002) Mid-systolic septal deceleration: a new sign of left ventricular outflow tract obstruction obtained by color-coded tissue Doppler echocardiography. Z Kardiol 92:1003-1007
2. Delacretas E, William G, Stevenson WG, Winters GL, Mitchell RN, Stewart S, Lynch K, Friedman P (1998) Ablation of ventricular tachycardia with a saline-cooled radiofrequency catheter: anatomic and histologic characteristics of lesions in humans. J Cardiovasc Electrophysiol 10:860-865
3. Faber L, Seggewiss H, Fassbender D, Bogunovic N, Strick S, Schmidt HK, Gleichmann U (1998) Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography. Z Kardiol 87:191-201
4. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H (2002) Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy. New York Heart Association functional class III and IV, and outflow tract obstruction only under provocable conditions. Circulation 106:454-495
5. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, Kuhn H (1999) Acute and long term results after transcoronary ablation of septum hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 20:1342-1354
6. Kuhn (2000) Transcoronary ablation of septal hypertrophy (TASH) in HOCM: a fife year experience. Z Kardiol 89:559-564
7. Kuhn H, Gietzen F, Breithardt G, Röhrig FR, Lieder F, Götsch U, Schulte HD, Freick M (2001) Pacemaker therapy and alcohol ablation for HOCM: a randomized study. Eur Heart J (Abstr Suppl)22:20
8. Kuhn H, Gietzen F, Leuner C, Gerenkamp T (1997) Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846-851
9. Kuhn H, Gietzen FH, Leuner C, Schäfers M, Schober O, Strunk-Müller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U (2000) Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 89(Suppl 4):IV41-IV54
10. Kuhn H, Lawrenz T, Lieder F, Gietzen FH, Obergassel L, Strunk-Müller C, Stolle B, Leuner CH (2004) Alcohol septal ablation in the treatment of hypertrophic obstructive cardiomyopathy: a seven-year experience. In: Maron BJ (ed) Diagnosis and management of hypertrophic cardiomyopathy. Blackwell (in press)
11. Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L (2004) Catheter based therapy for hypertrophic obstructive cardiomyopathy: first in hospital outcome analysis of the German TASH-registry. Z Kardiol 93:23-31
12. Lackis NM, Nagueh SF, Dunn JK, Killip D, Spencer WH (2000) Non surgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow up. J Am Coll Cardiol 36:852-855
13. Lawrenz T, Gietzen F, Lieder F, Obergassel L, Kuhn H (2002) Prognosis of patients with hypertrophic obstructive cardiomyopathy after transcoronary ablation of septal hypertrophy (TASH). Eur Heart J 4(Abst Suppl):734
14. Lawrenz T, Lieder F, Leuner CJ, Obergassel L, Gockel B, Strunk-Mueller C, Kuhn H (2003) What is the correct amount of ethanol in the catheter based treatment for hypertrophic obstructive cardiomyopathy Eur Heart J 24(Abstr Suppl):136
15. Leonelli FM, Natale A, O'Connor W (1999) Human histopathologic findings following radiofrequency ablation of the tricuspid-inferior vena cava isthmus. J Cardiovasc Electrophysiol 10:599-602
16. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH, Spirito P, Ten Cate FJ, Wigle ED (2003) Clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American college of cardiology task force on clinical expert consensus documents and the European society of cardiology committee for practice guidelines. J Am Coll Cardiol 42:1687-1713
17. Nakagawa H, Yamanashi WS, Pitha JV, Arruda M, Wang X, Ohtomo K, Beckman KJ, McClelland JH, Jazzara R, Jackman WM (1995) Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation. Circulation 91:2263-2273
18. Raute-Kreinsen U (2003) Morphology of necrosis and repair after transcoronary ethanol ablation of septal hypertrophy. Pathol Res Pract 199:121-127
19. Ruffy R, Imran MA, Santel DJ, Wharton JM (1995) Radiofrequency delivery through a cooled catheter tip allows the creation of larger endomyocardial lesions in the ovine heart. J Cardiovasc Electrophysiol 6:1089-1096
20. Schwarzkopff B, Stark P, Schulte, Mundhenke M, Klein RM, Lösse B, Vester EG, Strauer BE (1997) Early changes in systolic and diastolic function at rest and under exercise in patients with hypertrophic cardiomyopathy (HOCM) after myectomy. Z Kardiol 86:438-449
21. Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211-214
22. Skrumeda LL, Mehra R (1998) Comparison of standard and irrigated radiofrequency ablation in the canine ventricle. J Cardvasc Electrophysiol 9:1196-1205